Is there a link between ovulation induction and cancer?
Although there have been no clinical trials to conclusively establish a cause-and-effect relationship between ovulation induction with clomiphene citrate or gonadotropins and cancer, evidence derived from prospective and cohort studies suggests the following:
Although there have been no clinical trials to conclusively establish a cause-and-effect relationship between ovulation induction with clomiphene citrate or gonadotropins and cancer, evidence derived from prospective and cohort studies suggests the following:
Ovarian cancer: No correlation between fertility drugs and ovarian cancer exists, but nulligravid women and those with borderline ovarian tumors or certain tumor histologies may be at increased risk.
Breast cancer: Studies to date have had conflicting results, showing both increases as well as decreases in risk. Given that breast cancer is widely held to have a hormonal etiology, further studies examining a possible association between the disease and ovulation-inducing agents are needed.
Brinton LA, Moghissi KS, Scoccia B, et al. Ovulation induction and cancer risk. Fertil Steril. 2005;83:261-274.
EHR-based models show promise in predicting postpartum depression
December 24th 2024Recent research published highlights the potential of electronic health record data to improve postpartum depression diagnosis, offering a step toward better mental health outcomes for birthing parents.
Read More
Midlife sexual health boosts for nonheterosexual women reported
December 23rd 2024A recent study highlights improved sexual function and reduced distress among nonheterosexual women during menopause compared to their heterosexual counterparts, shedding light on how sexual identity impacts well-being.
Read More
